Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Clinical Investigation

• Publication date

  1995-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI118326PMID 8675626PMCID PMC185966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular Cholesterol Efflux Mediated by Cyclodextrins

  1996cited by this paper
• Effects of Acceptor Particle Size on the Efflux of Cellular Free Cholesterol (*)

  1995cited by this paper
• Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.

  1995cited by this paper
• Low level quantification of cholesteryl ester transfer protein in plasma subfractions and cell culture media by monoclonal antibody-based immunoassay.

  1995cited by this paper
• Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides.

  1995influential reference
• Cellular Cholesterol Efflux Mediated by Cyclodextrins (*)

  1995cited by this paper
• Molecular physiology of reverse cholesterol transport.

  1995cited by this paper
• The Effect of High Density Lipoprotein Phospholipid Acyl Chain Composition on the Efflux of Cellular Free Cholesterol (*)

  1995influential reference
• Quantification of apolipoproteins B-100, B-48, and E in human triglyceride-rich lipoproteins.

  1995cited by this paper
• Overexpression of human apolipoprotein A-I in transgenic rats and the hyperlipoproteinemia associated with experimental nephrosis.

  1995cited by this paper
• Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels.

  1994cited by this paper
• Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.

  1994cited by this paper
• A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells.

  1994cited by this paper
• A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer.

  1994influential reference
• ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

  1994cited by this paper
• The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.

  1994cited by this paper
• Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.

  1994cited by this paper
• Extravascular circulation of lipoproteins: their role in reverse transport of cholesterol.

  1994cited by this paper
• Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations.

  1993cited by this paper
• Protein composition determines the anti-atherogenic properties of HDL in transgenic mice

  1993cited by this paper
• Plasma cholesteryl ester transfer protein.

  1993cited by this paper
• Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: proposal of a putative model for the pre-beta high-density lipoprotein pathway.

  1992cited by this paper
• An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.

  1992influential reference
• Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol.

  1992cited by this paper
• Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol.

  1992cited by this paper
• α-Helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux

  1992cited by this paper
• Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI

  1991cited by this paper
• Cholesterol distribution between high-density-lipoprotein subfractions HDL2 and HDL3 determined in serum by discontinuous gradient gel electrophoresis.

  1991cited by this paper
• Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice.

  1991cited by this paper
• Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters.

  1991cited by this paper
• Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.

  1991cited by this paper
• Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells.

  1990cited by this paper
• Lipoproteins of human peripheral lymph.

  1990cited by this paper
• Initial steps in reverse cholesterol transport: the role of short-lived cholesterol acceptors.

  1990influential reference
• Lipoproteins in interstitial fluid of dogs: implications for a role in reverse cholesterol transport.

  1990cited by this paper
• High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.

  1989cited by this paper
• Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived choleste

  1989cited by this paper
• Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.

  1989cited by this paper
• Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein.

  1988cited by this paper
• Tissue-specific posttranslational modification of rat apoE. Synthesis of sialated apoE forms by neonatal rat aortic smooth muscle cells.

  1988cited by this paper
• Mechanisms and consequences of cellular cholesterol exchange and transfer.

  1987cited by this paper
• Role of apolipoproteins in cellular cholesterol efflux.

  1986cited by this paper
• [Reverse cholesterol transport].

  1986cited by this paper
• The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine.

  1986cited by this paper
• Atherosclerosis and lipoprotein metabolism: role of reverse cholesterol transport.

  1986cited by this paper
• Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

  1983cited by this paper
• Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma.

  1983cited by this paper
• Evidence for the separation of albumin- and apo A-I-dependent mechanisms of cholesterol efflux from cultured fibroblasts into human plasma.

  1982cited by this paper
• The effects of serum albumin and phospholipid on sterol excretion in tissue culture cells.

  1978cited by this paper
• Enzymatic assay for cholesterol ester hydrolase activity.

  1978cited by this paper
• Cellular cholesterol ester accumulation induced by free cholesterol-rich lipid dispersions.

  1976cited by this paper
• Cholesterol excretion by tissue culture cells: effect of serum lipids.

  1969cited by this paper
• The plasma lecithins:cholesterol acyltransferase reaction.

  1968cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper

• Human cholesteryl ester transport protein transgene promotes macrophage reverse cholesterol transport in C57BL/6 mice and phospholipid transfer protein gene knockout mice

  2021cites this paper
• A critical appraisal of the measurement of serum 'cholesterol efflux capacity' and its use as surrogate marker of risk of cardiovascular disease.

  2018cites this paper
• Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport

  2016cites this paper
• Humans With Atherosclerosis Have Impaired ABCA1 Cholesterol Efflux and Enhanced High-Density Lipoprotein Oxidation by Myeloperoxidase

  2014cites this paper
• HDL-targeted therapies: progress, failures and future

  2014cites this paper
• Macrophage-Independent Regulation of Reverse Cholesterol Transport by Liver X Receptors

  2014cites this paper
• Low High-Density Lipoprotein Cholesterol

  2012cites this paper
• Improving cardiovascular disease prevention : from risk assessment to novel therapy

  2009cites this paper
• The puzzle of high-density lipoprotein in cardiovascular prevention

  2009cites this paper
• Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.

  2006cites this paper
• Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice.

  2006cites this paper
• Endothelial lipase: its role in cardiovascular disease.

  2006cites this paper
• Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes1

  2006cites this paper
• Cholesteryl Ester Transfer Protein ( CETP ) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels Pathways by Which Modulation of CETP Activity May Alter Atherogenesis

  2006cites this paper
• ATVB In Focus: Novel Approaches to the Treatment of Dyslipidemia

  2005cites this paper
• Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein: An Initial Multidose Study of Torcetrapib

  2004cites this paper
• Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1 Published, JLR Papers in Press, July 1, 2004. DOI 10.1194/jlr.M400109-JLR200

  2004cites this paper
• In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux Published, JLR Papers in Press, November 1, 2003. DOI 10.1194/jlr.M300231-JLR200

  2004cites this paper
• HDL: a molecular view of the "classic" antiatherogenic lipoprotein

  2002cites this paper
• Mast Cell Chymase Degrades ApoE and ApoA-II in ApoA-I–Knockout Mouse Plasma and Reduces Its Ability to Promote Cellular Cholesterol Efflux

  2002cites this paper
• Arg123-Tyr166 Domain of Human ApoA-I Is Critical for HDL-Mediated Inhibition of Macrophage Homing and Early Atherosclerosis in Mice

  2001cites this paper
• Roles of plasma lipid transfer proteins in reverse cholesterol transport.

  2001cites this paper
• High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport.

  2001cites this paper
• High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function.

  2000cites this paper
• Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.

  2000cites this paper
• Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum.

  2000cites this paper
• Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.

  2000cites this paper
• Cholesterol homeostatic mechanisms in transgenic mice with altered expression of apoproteins A-I, A-II and A-IV.

  2000cites this paper
• High Density Lipoprotein Phospholipid Composition Is a Major Determinant of the Bi-directional Flux and Net Movement of Cellular Free Cholesterol Mediated by Scavenger Receptor BI*

  2000cites this paper
• Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice.

  1999cites this paper
• Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes.

  1999cites this paper
• Remodelling of high density lipoproteins by plasma factors.

  1999cites this paper
• Potencies of lipoproteins in fasting and postprandial plasma to accept additional cholesterol molecules released from cell membranes.

  1998cites this paper
• Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport.

  1998cites this paper
• Sterol Regulatory Element Binding Protein-1 Activates the Cholesteryl Ester Transfer Protein Gene in Vivobut Is Not Required for Sterol Up-regulation of Gene Expression*

  1998cites this paper
• Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice.

  1998cites this paper
• Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.

  1998influential citation
• Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man.

  1998cites this paper
• Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice.

  1997cites this paper
• Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells.

  1997cites this paper
• Lipoproteins and cellular cholesterol homeostasis.

  1997cites this paper
• The role of cholesteryl ester transfer protein and phospholipid transfer protein in the remodeling of plasma high-density lipoproteins.

  1997cites this paper
• HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum.

  1997cites this paper
• Cetp and exchangeable apoproteins. Common features in lipid binding activity

  1997cites this paper
• Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats.

  1996cites this paper
• Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes.

  1996cites this paper
• Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene.

  1996cites this paper